Search Results 1631-1640 of 15407 for Hepatitis b

1. A Study To Evaluate Safety And Effectiveness Of SHP647 As Induction Therapy In Participants With Moderate-to- Severe Crohn's Disease - Mayo Clinic

   Subjects with evidence of positive hepatitis B surface antigen (HBsAg) or hepatitis B core antibody (HBcAb). Note: If a subject tests negative for HBsAg ...

2. Mesenchymal Stem Cell Therapy For Lung Rejection - Mayo Clinic

   Positive screening for HIV Hepatitis B and Hepatitis C. Evidence of liver dysfunction; Liver profile showing alkaline phosphatase higher than 345 u/L, total ...

3. A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients - Mayo Clinic

   ... b-cell lymphoma (DLBCL) patients with out of specification ... Patients with active replication of Hep B or active or latent Hep C. History ...

4. A Study Of Vutrisiran (ALN-TTRSC02) In Patients With Hereditary Transthyretin Amyloidosis (HATTR Amyloidosis) - Mayo Clinic

   Has known human immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis B virus (HBV) infection. Received an experimental drug within 30 days of ...

5. Dose Escalation Study Of I-131-CLR1404 In Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   Known history of HIV, hepatitis C or hepatitis B infection; Pregnancy or breast-feeding. Participating Mayo Clinic locations. Study statuses change often ...

6. A Study Evaluating The Safety, Tolerability, Preliminary Drug/Body Interactions And Biological Activity Of MYK-461 - Mayo Clinic

   ... hepatitis C virus (HCV) or hepatitis B virus (HBV). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

7. Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

   Positive for Hepatitis B, Hepatitis C, or Human Deficiency Virus; Severe Renal Impairment; Contraindications for MRI. Participating Mayo Clinic locations. Study ...

8. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

   Hepatitis B surface antigen (HBsAg) positive. Hepatitis C antibody (HCVAb) positive with the following 2 exceptions: Subjects previously treated for viral ...

9. A Safety To Evaluate The Safety And Effectiveness Of Pressurized Intraperitoneal Aerosolized Chemotherapy In Ovarian, Uterine, Colorectal, And Gastric Cancer Patients - Mayo Clinic

   For patients with a known history of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.

10. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

    ... Hepatitis B, Nonalcoholic fatty liver disease, Portal hypertension, Ascites, Alcoholic hepatitis · Nahid Y. Vidal, M.D.. Rochester, MN ...